Treatment was a combination of laquinimod and fumaric acid dimethyl of multiple sclerosis

摘要

The present invention is a method of treating a subject suffering from multiple sclerosis or a clinically isolated syndrome subject, wherein laquinimod is administered to the subject as an additional therapy for DMF or in combination with DMF There is provided a method comprising: The present invention also provides a package comprising laquinimod and fingolimod for treating a subject suffering from multiple sclerosis or a subject presenting a clinically isolated syndrome. The present invention also provides laquinimod for use as an additional therapy for DMF or in combination with DMF in treating a subject suffering from multiple sclerosis or a subject with a clinically isolated syndrome. The present invention also provides a pharmaceutical composition comprising laquinimod and DMF for treating a subject suffering from multiple sclerosis or a subject presenting a clinically isolated syndrome. The present invention further provides the use of laquinimod and DMF in the preparation of a combination for treating a subject suffering from multiple sclerosis or a subject presenting a clinically isolated syndrome. [Selection figure] None